文献速递神经肿瘤

医疗补助保险对内镜下经蝶窦垂体手术结局的影响

Impact of Medicaid insurance on outcomes following endoscopic transsphenoidal pituitary surgery.
PubMed 文献 · J Neurosurg · 2020-03-20

该研究分析2005至2018年纽约长老会医院584例内镜下经蝶窦垂体腺瘤手术患者,其中57例(10%)为医疗补助保险。医疗补助患者肿瘤最大径更大、并发症发生率更高、长期颅神经病变更多、术后住院时间更长,内分泌和视力结局及30天再入院率无显著差异。

要点

  • 医疗补助患者肿瘤最大径26.1±12 mm,对照组23.1±11 mm,差异有统计学意义(p<0.05)。
  • 医疗补助患者任何并发症发生率14%,对照组7%;长期颅神经病变5%,对照组1%(均p<0.05)。
  • 医疗补助患者术后平均住院时间9.4±31天,对照组3.6±3天(p<0.05),排除离群值后仍显著。

核心结论

  • 作者发现医疗补助保险与更大的肿瘤直径、更长的术后住院时间、更高的并发症发生率和长期颅神经病变显著相关。
  • 基线合并症、卒中、内分泌结局、视力结局或30天再入院率无统计学显著差异。

研究设计与样本

  • 分析2005至2018年纽约长老会医院威尔康奈尔医学院前瞻性采集的内镜下经蝶窦垂体腺瘤手术数据库。
  • 共584例患者,其中57例(10%)为医疗补助保险,其余非医疗补助保险患者作为对照组。
  • 使用Pearson卡方检验和Fisher精确检验分析分类变量,独立样本t检验分析连续变量,α<0.05为统计学显著。

主要发现

  • 医疗补助患者肿瘤最大径26.1±12 mm,对照组23.1±11 mm(p<0.05)。
  • 医疗补助患者任何并发症发生率14%,对照组7%(p<0.05);长期颅神经病变5%,对照组1%(p<0.05)。
  • 医疗补助患者术后平均住院时间9.4±31天,对照组3.6±3天(p<0.05);排除离群值后为5.6±2.5天 vs 对照组3.0±2.7天(p<0.05)。
  • 医疗补助患者住院时间超过1个标准差的最常见原因为围手术期并发症管理和出院安置困难。
  • 30天再入院率医疗补助患者7%,对照组4.4%,差异无统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite the rise of studies in the neurosurgical literature suggesting that patients with Medicaid insurance have inferior outcomes, there remains a paucity of data on the impact of insurance on outcomes after endonasal endoscopic transsphenoidal surgery (EETS). Given the increasing importance of complications in quality-based healthcare metrics, the objective of this study was to assess whether Medicaid insurance type influences outcomes in EETS for pituitary adenoma. METHODS: The authors analyzed a prospectively acquired database of EETS for pituitary adenoma from 2005 to 2018 at NewYork-Presbyterian Hospital, Weill Cornell Medicine. All patients with Medicaid insurance were identified. As a control group, the clinical, socioeconomic, and radiographic data of all other patients in the series with non-Medicaid insurance were reviewed. Statistical significance was determined with an alpha < 0.05 using Pearson chi-square and Fisher's exact tests for categorical variables and the independent-samples t-test for continuous variables. RESULTS: Of 584 patients undergoing EETS for pituitary adenoma, 57 (10%) had Medicaid insurance. The maximum tumor diameter was significantly larger for Medicaid patients (26.1 ± 12 vs 23.1 ± 11 mm for controls, p < 0.05). Baseline comorbidities including diabetes mellitus, hypertension, smoking history, and BMI were not significantly different between Medicaid patients and controls. Patients with Medicaid insurance had a significantly higher rate of any complication (14% vs 7% for controls, p < 0.05) and long-term cranial neuropathy (5% vs 1% for controls, p < 0.05). There were no statistically significant differences in endocrine outcome or vision outcome. The mean postoperative length of stay was significantly longer for Medicaid patients compared to the controls (9.4 ± 31 vs 3.6 ± 3 days, p < 0.05). This difference remained significant even when accounting for outliers (5.6 ± 2.5 vs 3.0 ± 2.7 days for controls, p < 0.05). The most common causes of extended length of stay greater than 1 standard deviation for Medicaid patients were management of perioperative complications and disposition challenges. The rate of 30-day readmission was 7% for Medicaid patients and 4.4% for controls, which was not a statistically significant difference. CONCLUSIONS: The authors found that larger tumor diameter, longer postoperative length of stay, higher rate of complications, and long-term cranial neuropathy were significantly associated with Medicaid insurance. There were no statistically significant differences in baseline comorbidities, apoplexy, endocrine outcome, vision outcome, or 30-day readmission.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Younus I, Gerges M, Schwartz TH, et al. Impact of Medicaid insurance on outcomes following endoscopic transsphenoidal pituitary surgery. J Neurosurg. 2020. PMID: 32197242. doi:10.3171/2020.1.JNS192707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。